Thomas Flaten

Stock Analyst at Lake Street

(0.98)
# 2280
Out of 5,396 analysts
47
Total ratings
Success rate
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
AYTU Aytu BioPharma
Initiates Coverage On: Buy
8
2.38 236.13% 1 Jul 1, 2025
OCX OncoCyte
Maintains: Strong Buy
5 8
3.2 150% 6 May 21, 2025
BDSX Biodesix
Maintains: Buy
3 2
n/a n/a 1 May 14, 2025
CSTL Castle Biosciences
Maintains: Buy
40 35
20.3 72.41% 6 May 6, 2025
OPTN OptiNose
Downgrades: Hold
17 9
9.6 -6.25% 5 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
4.26 -3.76% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
3.72 115.05% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 6
2.39 151.05% 2 Feb 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 9
7.45 20.81% 2 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
7.1 26.76% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
1
n/a n/a 1 Apr 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
0.65 361.54% 3 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 11
2.18 404.59% 3 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
n/a n/a 2 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 25
22.84 9.46% 2 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14400 1440
2.31 62237.66% 2 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 8
3.76 112.77% 1 Jul 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 May 13, 2022